Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/2012
10/16/2012US8287857 Immunotherapy with in vitro-selected antigen-specific lymphocytes after nonmyeloablative lymphodepleting chemotherapy
10/16/2012US8287852 Treatment of viral diseases with recombinant interferon α
10/16/2012US8287851 Use of interleukin 17E for the treatment of cancer
10/16/2012US8287850 Conjugates of hydroxyalkyl starch and a protein, prepared by reductive amination
10/16/2012US8287849 Biodegradable poly(beta-amino esters) and uses thereof
10/16/2012CA2714757C Low viscosity liquid polymeric delivery system
10/16/2012CA2614615C Melanocortin receptor ligands
10/16/2012CA2577550C Use of the combination comprising temozolomide and tnf-alpha for treating glioblastoma
10/16/2012CA2544155C Drug and method for proliferating natural killer cells
10/16/2012CA2533753C Drug for cancer therapy
10/16/2012CA2530756C Methods for obtaining molecules with reduced immunogenicity
10/16/2012CA2516028C Conjugates comprising a cancer targeting molecule linked to a liver-expressed chemokine
10/16/2012CA2504933C Methods and compositions for treating cancer using proteasome inhibitors
10/16/2012CA2480696C Peptide epitopes common to antigens of the same multigene family
10/16/2012CA2466773C Inhibitor oligonucleotides and their use for specific repression of a gene
10/16/2012CA2453202C Peptides which modulate blood coagulation and methods of use thereof
10/16/2012CA2451847C A novel engineered superantigen for human therapy
10/16/2012CA2446781C Coated granules based on angiotensin-converting enzyme inhibitor
10/16/2012CA2443069C Synthesis and use of glycodendrimer reagents
10/16/2012CA2419404C Compositions and methods for treating sexual dysfunction
10/16/2012CA2404340C Methods of blocking tissue destruction by autoreactive t cells
10/16/2012CA2368357C Methods for treating congestive heart failure
10/16/2012CA2364300C A skin care composition that mediates cell to cell communication
10/16/2012CA2356257C Insulin-like growth factor (igf) i mutant variants
10/16/2012CA2329829C Protein purification by ion exchange chromatography
10/16/2012CA2250970C Cyclosporin emulsions
10/16/2012CA2223427C Collagen-based delivery matrix
10/16/2012CA2132873C Peptides useful for inducing tolerance
10/11/2012WO2012139137A2 Pepducin design and use
10/11/2012WO2012139099A2 Herpes simplex virus vaccine
10/11/2012WO2012139094A2 Method of developing a vaccine using peptide-poly ic complexes
10/11/2012WO2012138977A1 Structural based design of il-17 dominant negative mutants
10/11/2012WO2012138941A1 Compositions comprising glucagon analogs and methods of making and using the same
10/11/2012WO2012138939A1 New tale-protein scaffolds and uses thereof
10/11/2012WO2012138919A2 Method of treating or ameliorating metabolic disorders using growth differentiation factor 15 (gdf-15)
10/11/2012WO2012138879A2 Peptides for the treatment of hearing
10/11/2012WO2012138867A2 Long-acting peptide analogs
10/11/2012WO2012138846A2 Method and compositions comprising small rna agonist and antagonists to modulate inflammation
10/11/2012WO2012138839A1 Bpi and its congeners as radiation mitigators and radiation protectors
10/11/2012WO2012138708A1 Mhc engagement and clip modulation for the treatment of disease
10/11/2012WO2012138691A2 Diagnosis and treatment of taxane-resistant cancers
10/11/2012WO2012138599A2 Hepatocyte growth factor mimics as therapeutic agents
10/11/2012WO2012138441A1 Composition and method for topical treatment of skin lesions
10/11/2012WO2012138429A1 Molecularly imprinted polymers having affinity for natriuretic peptides
10/11/2012WO2012138294A1 Novel peptides that bind to types of mhc class ii and their use on diagnosis and treatment
10/11/2012WO2012138251A1 Octapeptide, radiopharmaceutical agent based thereon and method for diagnosing tumors
10/11/2012WO2012138246A1 Pharmaceutical composition for treating hyperproliferative diseases
10/11/2012WO2012137991A1 Pharmaceutical composition for the prevention or treatment of mucolipidosis ii, comprising a lysosomal enzyme as an active ingredient
10/11/2012WO2012137834A1 Method for producing endoplasmic reticulum
10/11/2012WO2012137683A1 Recombinant polypeptide production method
10/11/2012WO2012137645A1 Preventive and/or therapeutic agent for allodynia caused by anticancer agent
10/11/2012WO2012137538A1 Cytotoxic t cell inducing composition
10/11/2012WO2012137199A1 Macrophage activating factor for pharmaceutical compositions
10/11/2012WO2012136909A2 Thixotropic α-lactalbumin hydrogels, method for preparing same and uses thereof
10/11/2012WO2012136857A1 Drug containing recombinant mistletoe lectins for treating malignant melanoma
10/11/2012WO2012136851A1 Methods and pharmaceutical compositions for inhibiting influenza viruses replication
10/11/2012WO2012136829A1 Novel combination treatment of cancer
10/11/2012WO2012136819A1 Therapeutic and prophylactic methods, uses and compositions comprising anexin a5
10/11/2012WO2012136768A1 Use of mutants of human hyaluronidase ph-20 with increased chondroitinase activity for axonal regrowth
10/11/2012WO2012136739A1 Method for treating ifnalpha related conditions
10/11/2012WO2012136685A1 Methods and compositions for anti-vegf and anti-c-met therapy
10/11/2012WO2012136587A1 Repair of neurodegenerative disease
10/11/2012WO2012136543A1 Use of a hypoallergenic cereal composition for including specific oral tolerance
10/11/2012WO2012136369A1 Ophthalmic preparations based on pacap (pituitary adenylate cyclase activating polypeptide) which restore the normal visual function in early glaucoma
10/11/2012WO2012136312A1 Peptides for suppressing inflammation reactions in hemodialysis
10/11/2012WO2012136309A1 Melanocyte-stimulation hormone for suppressing inflammation reactions in hemodialysis
10/11/2012WO2012136224A2 Methods and compositions for enhancing pulmonary host defense in acute and chronic radiation syndrome, therapeutic radiation intervention and cancer therapy
10/11/2012WO2012136204A2 Preparation or dietary supplement
10/11/2012WO2012136172A1 Method for producing injectable formulations of blood-derived protein materials, and materials obtained using said method
10/11/2012WO2012135951A1 Oral enzyme compositions for intestinal delivery
10/11/2012WO2012135905A1 Tam receptor ligands, metabolites and precursors thereof in the detection and modulation of inflammatory neuropathological disease
10/11/2012WO2012112869A3 Targeted cancer therapy using ets transcriptional inhibitors
10/11/2012WO2012103360A3 Wnt compositions and methods of use thereof
10/11/2012WO2012098397A4 Combination therapy for cancer
10/11/2012WO2012097057A3 Methods, compositions and kits for modulating trans-differentiation of muscle satellite cells
10/11/2012WO2012092114A3 Oxidosqualene cyclase as a protein target for anticancer therapeutics
10/11/2012WO2012091449A3 Pharmaceutical composition comprising phosphorylated grasp for treating cystic fibrosis
10/11/2012WO2012088425A9 Gap junction-enhancing agents for treatment of necrotizing enterocolitis and inflammatory bowel disease
10/11/2012WO2012074330A3 Fusion peptide comprising dhfas-1 domain and mmp substrate and use thereof for preventing and treating rheumatoid arthritis
10/11/2012WO2012046008A3 Inhibitors of pde4 binding to hsp20
10/11/2012US20120260356 Meganuclease variants cleaving at least one target in the genome of a retrovirus and uses thereof
10/11/2012US20120259318 Solvent/polymer solutions as suspension vehicles
10/11/2012US20120259151 Pyridopyrazine derivatives and their use
10/11/2012US20120259093 Expression of secreted human alpha-fetoprotein in transgenic animals
10/11/2012US20120258921 Peptides for the treatment of hearing
10/11/2012US20120258920 Peptides and aptamers thereof as specific modulators of mutant p53 function
10/11/2012US20120258919 Collagen peptide, dipeptide and malady inhibitor
10/11/2012US20120258918 Polypeptoid pulmonary surfactants
10/11/2012US20120258917 Peripheral Administration of Proteins Including TGF-beta Superfamily Members for Treatment of Systemic Disorders and Disease
10/11/2012US20120258916 Ophthalmic preparations based on bdnf (brain-derived neurotrophic factor) and their use
10/11/2012US20120258915 Proteolysis Resistant Active VEGF
10/11/2012US20120258914 Coacervation process
10/11/2012US20120258913 Glucopyranoside compound
10/11/2012US20120258912 Pharmaceutical compositions and methods for delivering such compositions
10/11/2012US20120258911 Phenylalkylcarboxylic acid delivery agents
10/11/2012US20120258909 Solid Compositions
10/11/2012US20120258908 Oligoadenylate synthetase (oas)
10/11/2012US20120258907 Treatment of fungal and/or protist infections
10/11/2012US20120258906 Use of peptides as antidandruff agents
10/11/2012US20120258905 Vitamin receptor drug delivery conjugates for treating inflammation
1 ... 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 ... 3163